Déficit de atención e hiperactividad: previniendo el sobrediagnóstico y el sobretratamiento

Autores/as

  • Jean-Claude St-Onge Philosophy Professor (retired). M.A. Philosophy, PhD. Socio-economics. Québec, Canada.

DOI:

https://doi.org/10.5712/rbmfc10(35)1014

Palabras clave:

Transtorno do Déficit de Atenção com Hiperatividade, Medicalização Efetividade, efeitos adversos, Prevenção Quaternária

Resumen

La primera parte de este artículo se centra en las amplias variaciones en el diagnóstico del trastorno de hiperactividad por déficit de atención (TDAH) que se observan entre países y entre regiones dentro de un mismo país. El diagnóstico de TDAH es más problemático de lo que se piensa comúnmente. Por ejemplo, los niños estadounidenses más jóvenes en el mismo grado en la escuela son 64% más propensos a recibir el diagnóstico y los síntomas pueden ser el resultado de muchas causas subyacentes. Además, el TDAH se puede confundir con muchas otras cuestiones de salud. Como resultado, el TDAH és ampliamente sobrediagnosticado y sobretratado. La segunda parte del artículo revisa estudios recientes que muestran que las drogas anti-TDAH carecen de eficacia a largo plazo y cuentan con eventos adversos importantes. En general, y en el largo plazo, el tratamiento farmacológico del TDAH es probable que cause más daños que beneficios.

Descargas

Los datos de descargas todavía no están disponibles.

Métricas

Cargando métricas ...

Biografía del autor/a

Jean-Claude St-Onge, Philosophy Professor (retired). M.A. Philosophy, PhD. Socio-economics. Québec, Canada.

Philosophy Professor (retired) M.A. Philosophy, PhD. Socio-economics.

Citas

Centers for Disease Control and Prevention (CDC). Data and statistics. New data: medication and behavior treatment [Internet]. Clifton Road Atlanta, GA: United States. U.S. Department of Health & Human Services; 2015 [cited 2015 Jun 18]. Available from: http://www.cdc.gov/ncbddd/adhd/data.html

Cohen D. ADHD in France and in America [Internet]. In: Mad in America: Science, Psychiatry and Community. 2013 [cited 2013 Sept 30]. Available from: http://www.madinamerica.com/2013/09/adhd-france-america/

Von Blech J. Schwermut ohne Scham. Der Spiegel, 2012 Jun 2. 2015 [cited 2015 June 18] Available from: http://www.spiegel.de/spiegel/print/d-83865282.html.

Rettner R. Doc Shouldn’t Give ADHD Drugs to Healthy Kids [Internet]. In: Live Science. 2013 [cited 2013 Mar 13]. Available from: http://www.livescience.com/27884-adhd-drugs-healthy-kids-prescribing.html

Papin F. “N’achetez pas le DSM-5”, recommande le Dr Allen Frances, père du DSM-IV [Internet]. In: Institut du développement de l’enfant et de la famille. 2013 [cited 2013 Sep 30]. Available from: https://www.facebook.com/permalink.php?story_fbid=10151899309383841&id=252682718840

Haute Autorité de Santé. Conduite à tenir devant un enfant ou un adolescent ayant un déficit de l’attention et/ou un problème d’agitation. 2012 [cited 2015 Jun 18]. Available from: http://www.afpssu.com/wp-content/uploads/2013/07/trouble-de-lattention-de-lenfant_note_de_cadrage.pdf

Institut de la statistique du Québec. L’Enquête québécoise sur la santé des jeunes du secondaire. Tome 2: Le visage des jeunes d’aujourd’hui: leur santé mentale et leur adaptation sociale 2010-2011. Québec, FR: Institut de la statistique du Québec; 2013.

Swanson JM, Sergeant JA, Taylor E, Sonuga-Barke EJS, Jensen PS, Cantwell DP. Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet. 1998;351(9100):429-433.[Accessed Jun 18 2015]. http://dx.doi.org/10.1016/S0140-6736(97)11450-7. PMid:9482319. DOI: https://doi.org/10.1016/S0140-6736(97)11450-7

Gonon F, Cohen D. Le trouble déficitaire de l’attention avec hyperactivité : La génétique est-elle impliquée? Med Sci (Paris). 2011;27(3):315-317. http://dx.doi.org/10.1051/medsci/2011273315. PMid:21447307. DOI: https://doi.org/10.1051/medsci/2011273315

Kupfer D. Statement by David Kupfer, MD [Internet]. In: American Psychiatric Association. Arlington, VA: American Psychiatric Association; 2013 [Accessed: Jun 18 2015]. Available from: http://www.psych.org/File%20Library/Advocacy%20and%20Newsroom/Press%20Releases/2013%20Releases/13-33-Statement-from-DSM-Chair-David-Kupfer--MD.pdf

Guay MC, Lageix P, Parent V. Proposition d’une démarche évaluative du TDAH. In: Chevalier N, Guay MC, Achim A, Lageix P, Poissant H, editors. Trouble déficitaire de l’attention avec hyperactivité. Soigner, éduquer, surtout valoriser. Montréal: l’Université du Québec; 2006. 5 p.

Elder TE. The importance of relative standards in ADHD diagnoses: evidence based on exact birth dates. J Health Econ. 2010;29(5):641-656. http://dx.doi.org/10.1016/j.jhealeco.2010.06.003. PMid:20638739. DOI: https://doi.org/10.1016/j.jhealeco.2010.06.003

Dotinga R. Youngest kids in class may be more likely to get ADHD diagnosis [Internet]. In: Health Day. 2012 [cited 2015 Jun 18]. Available from: http://consumer.healthday.com/kids-health-information-23/attention-deficit-disorder-adhd-news-50/youngest-kids-in-class-may-be-more-likely-to-get-adhd-diagnosis-670784.html

Holmberg K, Sundelin C, Hjern A. Screening for attention-deficit/hyperactivity disorder (ADHD): can high-risk children be identified in first grade? Child Care Health Dev. 2013;39(2):268-276. http://dx.doi.org/10.1111/j.1365-2214.2012.01382.x. PMid:22515618. DOI: https://doi.org/10.1111/j.1365-2214.2012.01382.x

Thomas R, Mitchell GK, Batstra L. Attention-deficit/hyperactivity disorder: are we helping or harming? BMJ. 2013;347:f6172. [Accessed: 2015 Feb 3]. http://dx.doi.org/10.1136/bmj.f6172. PMid:24192646. DOI: https://doi.org/10.1136/bmj.f6172

Wolraich ML, Hannah JN, Baumgaertel A, Feurer ID. Examination of DSM-IV criteria for attention deficit/hyperactivity disorder in a county-wide sample. J Dev Behav Pediatr. 1998;19(3):162-168. http://dx.doi.org/10.1097/00004703-199806000-00003. PMid:9648041. DOI: https://doi.org/10.1097/00004703-199806000-00003

Parens E, Johnston J. Facts, values, and attention-deficit hyperactivity disorder (ADHD): an update on the controversies. Child Adolesc Psychiatry Ment Health. 2009;3(1):1-17. http://dx.doi.org/10.1186/1753-2000-3-1. PMid:19152690. DOI: https://doi.org/10.1186/1753-2000-3-1

Thakkar VG. Diagnosing the wrong deficit [Internet]. In: The New York Times Sunday Review. 2013 [cited 2013 Apr 27]. Available from: http://www.nytimes.com/2013/04/28/opinion/sunday/diagnosing-the-wrong-deficit.html?emc=eta1&_r=0.

Saul R. Doctor: ADHD does not exist [Internet]. In: Time. 2004 [cited 2015 Jun 18]. Available from: http://time.com/25370/doctor-adhd-does-not-exist/

Canadian ADHD Practice Guidelines (CAP-Guidelines) [Internet]. 3rd ed. Canada: Canadian ADHD Resource Alliance; 2010 [cited 2015 Jun 18y]. Available from: http://www.caddra.ca/cms4/pdfs/caddraGuidelines2011.pdf

Sroufe A. Ritalin Gone Wrong [Internet]. In: The New York Times Sunday Review. 2012 [cited 2012 Jan 28]. Available from: http://www.nytimes.com/2012/01/29/opinion/sunday/childrens-add-drugs-dont-work-long-term.html.

Braun JM, Kahn RS, Froehlich T, Auinger P, Lanphear BP. Exposures to environmental toxicants and attention deficit hyperactivity disorder in U.S. children. Environ Health Perspect. 2006;114(12):1904-1909. PMid:17185283. DOI: https://doi.org/10.1289/ehp.9478

Kirk SA, Gomory T, Cohen D. Mad Science: psychiatric coercion, diagnosis, and drugs. New Brunswick, NJ: Transaction Publishers; 2013. 166 p.

Insel T. Transforming Diagnosis [Internet]. In: National Institute of Mental Health. 2013 [cited 2015 Jun 18y]. Available from: http://www.nimh.nih.gov/about/director/2013/transforming-diagnosis.shtml

The Trumpet. Psych Illnesses Lack Scientific Basis [Internet]. 2007 [cited cited 2015 Jun 18]. Available from: http://www.thetrumpet.com/article/3819.2061.96.0/society/psych-illnesses-lack-scientific-basis?preview

Food and Drug Administration (FDA). Inspections, compliance, enforcement, and criminal investigations [Internet]. 2008 [cited 2008 Sept 25]. Available from: http://www.fda.gov/iceci/enforcementactions/warningletters/2008/ucm1048119.htm

Molina BS, Hinshaw SP, Swanson JM, Arnold LE, Vitiello B, Jensen PS, et al. The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry. 2009;48(5):484-500. http://dx.doi.org/10.1097/CHI.0b013e31819c23d0. PMid:19318991. DOI: https://doi.org/10.1097/CHI.0b013e31819c23d0

Smith G, Jongeling B, Hartmann P, Russell C, Landau L. Raine ADHD study: long-term outcomes associated with stimulant medication in the treatment of ADHD in children [Internet]. Austrália: Government of Western Australia; 2010 [cited 2015 Jun 18]. Available from: https://www.health.wa.gov.au/publications/documents/MICADHD_Raine_ADHD_Study_report_022010.pdf

Case Western Reserve University. FDA approves many drugs that predictably increase heart and stroke risk: case western reserve physician calls on FDA to address hidden risk [Internet]. 2014 [cited 2014 May 24]. Available from: http://casemed.case.edu/newscenter/news-release/newsrelease.cfm?news_id=212

Currie J, Stabile M, Jones LE. Do stimulant medications improve educational and behavioral outcomes in children with ADHD? Massachusetts: National Bureau of Economic Research; 2013 [cited 2015 Jun 18]. Available from: https://www.mcgill.ca/socialstatistics/files/socialstatistics/mark_stabile_oct_2_2013.pdf DOI: https://doi.org/10.3386/w19105

Riddle MA, Yershova K, Lazzaretto D, Paykina N, Yenokyan G, Greenhill L, et al. The preschool attention-deficit/hyperactivity disorder treatment study (PATS) 6-year follow-up. J Am Acad Child Adolesc Psychiatry. 2013;52(3):264-278. http://dx.doi.org/10.1016/j.jaac.2012.12.007. PMid:23452683. DOI: https://doi.org/10.1016/j.jaac.2012.12.007

Collingwood J. Side effects of ADHD medication [Internet]. In: PsychCentral. 2010 [cited 2015 Jun 18]. Available from: http://psychcentral.com/lib/side-effects-of-adhd-medications/0003782

St-Onge JC. Tous fous? L’influence de l’industrie pharmaceutique sur la psychiatrie. Montréal: Écosociété; 2013. 78 p.

Bruser D, Bailey A. ADHD drugs suspected of hurting canadian kids [Internet]. In: Toronto Star Newspapers. 2012 [cited 2012 Sept 26]. Available from: http://www.thestar.com/news/canada/2012/09/26/adhd_drugs_suspected_of_hurting_canadian_kids.html

Institute for Safe Medication Practices (ISMP). QuarterWatch Monitoring FDA MedWath Reports. Horsham; 2015 [cited 2015 June 18] Available from: http://www.ismp.org/QuarterWatch/.

Mantua Station Drug Co. ER visits linked to ADHD meds up sharply [Internet]. 2013 [cited 2015 Jun 18]. Available from: https://mantuastationrx.com/article.php?id=672868&category=DRAB

Larsson J. Confidential report reveals: Big Pharma trying to stop long-term safety studies of ADHD drugs (Ritalin, Concerta) [Internet]. In:TransWorldNews. 2010 [cited 2010 Apr 4]. Available from: http://www.transworldnews.com/NewsStory.aspx?StoryID=244733

The Dawn Report (DAWN). Emergency department visits involving Attention Deficit/Hyperactivity disorder stimulant medications [Internet]. 2013 [cited 2015 Jun 18]. Available from: http://archive.samhsa.gov/data/2k13/dawn073/sr073-add-adhd-medications.htm

Publicado

2015-06-24

Cómo citar

1.
St-Onge J-C. Déficit de atención e hiperactividad: previniendo el sobrediagnóstico y el sobretratamiento. Rev Bras Med Fam Comunidade [Internet]. 24 de junio de 2015 [citado 22 de julio de 2024];10(35):1-8. Disponible en: https://rbmfc.org.br/rbmfc/article/view/1014

Número

Sección

Artículos de Investigación

Plaudit